Early Referral Key to CAR-T Success in India, Doctors Say

Doctors at Fortis Institute of Blood Disorders say early referral is central to outcomes for NexCAR 19, India's first indigenous CAR-T therapy. They note CAR-T has expanded options for older and heavily pre-treated blood cancer patients who were previously ineligible for intensive treatment, with fitness and organ function guiding decisions rather than age alone.